BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Thermo Fisher & Boehringer Ingelheim Join Forces for NSCLC Companion Diagnostics in Japan and the US

To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...

October 20, 2023 | News

Fujitsu and TOPPAN Holdings collaborate to expand medical big data business

Fujitsu Limited and TOPPAN Holdings Inc. concluded a business alliance agreement to jointly promote the medical big data business with the aim of pro...

October 20, 2023 | News

Aculys Pharma's Positive Phase 3 Update on Diazepam Nasal Spray for Epileptic Seizures in Japan

These results are from Japan's first domestic Phase 3 clinical trial of an intranasally administered antiepileptic drug for Japanese patients a...

October 19, 2023 | News

Fujitsu and RIKEN develop AI drug discovery technology utilizing generative AI to predict structural changes in proteins

Fujitsu Limited and the HPC- and AI-driven Drug Development Platform Division of the RIKEN Center for Computational Science today announced that they have ...

October 11, 2023 | News

Fujirebio and Sysmex Enter into Basic Agreement on Business Collaboration in the Field of Immunoassay

Sysmex has built up a robust technological foundation as well as a global network in the in vitro diagnostics field through developing its busine...

October 11, 2023 | News

Sony Announces Launch of FP7000 Spectral Cell Sorter Supporting High-Parameter Sorting with More Than 44 Colors(*1)

Sony Corporation announced the launch of FP7000 spectral cell sorter that supports high-speed, high-parameter sorting with more than 44 colors with s...

October 10, 2023 | News

Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

The technologies licensed to Telethon are based on Takara Bio’s proprietary RetroNectin® method, which includes a technology enabling highly effi...

October 05, 2023 | News

Everest Medicines' Partner Calliditas Shares NefIgArd Phase 3 Trial Data at ISIN Tokyo 2023

"The positive findings from biomarker and patient subgroup analyses from the Phase 3 NefIgArd study highlights that Nefecon® treatment results in ...

October 05, 2023 | News

Hitachi's Proton Therapy System Now in Use at National Cancer Centre Singapore

This system, installed in the basement of the new building of NCCS with 24 floors above ground, consists of five treatment rooms, four with rotating gantri...

October 05, 2023 | News

Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan

Established in 1970, SRL Inc (a subsidiary of H.U Group Holdings Inc.), is a renowned clinical laboratory testing company in Japan with over 80 n...

October 03, 2023 | News

PHC and JCR Pharma Release Second Update for "Meron Diary" Growth Hormone Treatment App

Jointly developed by PHC IVD and JCR Pharma and released for the first time in October 2020, "Meron Diary" is a smartphone application that can wirelessly ...

October 02, 2023 | News

Fujitsu and Baptist Health South Florida Revolutionize OR Scheduling for Better Utilization and Finances

Recent trials with the solution delivered 37% improvement in available prime-time minutes over a three-month period Fujitsu announced the launch of an inn...

September 15, 2023 | News

Menarini's ELZONRIS® (Tagraxofusp) Receives Orphan Drug Designation for BPDCN by Japanese Ministry of Health

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-own...

August 31, 2023 | Regulatory

PeptiGrowth & Orizuru Therapeutics Partner for Synthetic Peptide Growth Factor

OZTx, with the aim of social implementation of cell therapy products and innovative iPS cell-related technologies (platform innovation), is conducting rese...

August 25, 2023 | News

Stay Connected